Aegerion (AEGR) Wins FDA Approval of Lomitapide in Lowering Cholesterol with HoFH Patients
Tweet Send to a Friend
Aegerion Pharmaceuticals, Inc. (Nasdaq: AEGR), said to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
